Literature DB >> 17643928

Polarization of B effector cells in Sjögren's syndrome.

Capucine Daridon1, Thomas Guerrier, Valérie Devauchelle, Alain Saraux, Jacques-Olivier Pers, Pierre Youinou.   

Abstract

Analysis of salivary glands of patients with primary Sjögren's syndrome has yielded conflicting results with respect to T helper (Th)1/Th2 polarization. This balance might parallel the progress of the local lesions. B-cells are now taking center stage in this disease. They can also be primed to differentiate into two cytokine-production pathways, dubbed B effector (Be) 1 and Be2 cells. This is discussed in the light of our recent finding that Be1 accompany Th1, while Be2 accompany in the tissue lesions.

Entities:  

Mesh:

Year:  2007        PMID: 17643928     DOI: 10.1016/j.autrev.2007.01.010

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  6 in total

Review 1.  Cytokine-producing B lymphocytes-key regulators of immunity.

Authors:  Frances E Lund
Journal:  Curr Opin Immunol       Date:  2008-04-15       Impact factor: 7.486

Review 2.  Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets.

Authors:  Jennifer H Anolik; R John Looney; Frances E Lund; Troy D Randall; Iñaki Sanz
Journal:  Immunol Res       Date:  2009-04-07       Impact factor: 2.829

3.  Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Marta Perez-De-Lis; Iratxe Jimenez; Maria-Jose Blanco; Albert Bove; Maria-Jose Soto; Miriam Akasbi; Candido Diaz; Juan Sentís; Antoni Siso
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 4.  Disturbance of cytokine networks in Sjögren's syndrome.

Authors:  Pierre Youinou; Jacques-Olivier Pers
Journal:  Arthritis Res Ther       Date:  2011-07-06       Impact factor: 5.156

5.  Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.

Authors:  Diana G Adlowitz; Jennifer Barnard; Jamie N Biear; Christopher Cistrone; Teresa Owen; Wensheng Wang; Arumugam Palanichamy; Ezinma Ezealah; Debbie Campbell; Chungwen Wei; R John Looney; Inaki Sanz; Jennifer H Anolik
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

6.  Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sjögren's syndrome treated with Infliximab: a pilot study.

Authors:  L K Anzola-Fuentes; M Chianelli; F Galli; A W J M Glaudemans; L Martin Martin; V Todino; A Migliore; A Signore
Journal:  EJNMMI Res       Date:  2016-06-04       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.